Jarawee Sukmanee

Jarawee Sukmanee

Auto-generated profile, based on publicly available information

Jarawee Sukmanee

Health Intervention and Technology Assessment Program Foundation (HITAP), Ministry of Public Health, Nonthaburi, Thailand

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJarawee Sukmanee
Jarawee Sukmanee
RBRukmanee Butchon
Rukmanee Butchon
MSMyka Harun Sarajan
Myka Harun Sarajan
TSThanayut Saeraneesopon
Thanayut Saeraneesopon
CBChulathip Boonma
Chulathip Boonma
Wanrudee IsaranuwatchaiWanrudee Isaranuwatchai
Wanrudee Isaranuwatchai
Introduction: Acute appendicitis is one of the most common surgical emergencies; however, optimal diagnosis and treatment of acute appendicitis remains challenging. We used the coronavirus disease 2019 (COVID-19) lockdown policy as a natural experiment to explore potential overdiagnosis and overtreatment of acute appendicitis in Thailand. The aim of this study was to estimate the potential overdiagnosis and overtreatment of acute appendicitis in Thailand by examining service utilization before, during, and after the COVID-19 lockdown policy.Methods: A secondary data analysis of patients admitted with acute appendicitis under the Universal Coverage Scheme (UCS) in Thailand over a 6-year period between 2016 and 2021 was conducted. The trend of acute appendicitis was plotted using a 14-day rolling average of daily cases. Patient characteristics, clinical management, and outcomes were descriptively presented and compared among three study periods, namely pre-pandemic, lockdown, and post-lockdown.Results: The number of overall acute appendicitis cases decreased from 25,407 during pre-pandemic to 22,006 during lockdown (13.4% reduction) and 21,245 during post-lockdown (16.4% reduction). This reduction was mostly due to a lower incidence of uncomplicated acute appendicitis, whereas cases of generalized peritonitis were scarcely affected by the pandemic. There was an increasing trend towards the usage of diagnostic computerized tomography for acute appendicitis but no significant difference in treatment modalities and complication rates.Conclusion: The stable rates of generalized peritonitis and complications during the COVID-19 lockdown, despite fewer admissions overall, suggest that there may have been overdiagnosis and overtreatment of acute appendicitis in Thailand. Policy makers could use these findings to improve clinical practice for acute appendicitis in Thailand and support the efficient utilization of surgical services in the future, especially during pandemics.

11 June 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
CCCynthia Chen
Cynthia Chen
JSJarawee Sukmanee
Jarawee Sukmanee
KSKhai Wee Soon
Khai Wee Soon
JLJulian Lim
Julian Lim
JDJared Louis Andre D'SOuza
Jared Louis Andre D'SOuza
Yot TeerawattananonYot Teerawattananon
Yot Teerawattananon
Background: With the vast development of technology and the evolving needs of patients and health care providers, electronic medical records (EMRs) have become a cornerstone for health information. However, different institutions have used different EMR systems. Our study investigates the potential benefits of implementing an integrated and common platform, known as the Next Generation Electronic Medical Record (NGEMR) in Singapore. The NGEMR allows improved data sharing between health care facilities and can promote better coordination between primary care and specialist care doctors to access patients’ records from the same database. Objective: This study aims to conduct an economic evaluation of the NGEMR to inform future health care system upgrades. Methods: A cost-utility analysis comparing NGEMR with the legacy EMR was conducted using a decision tree model with a 1-year time horizon from a health care system perspective. Input parameters of patients visiting primary care at the National University Polyclinics and specialist outpatient clinics from a General Hospital were extracted from the EMR systems. The incremental cost-effectiveness ratio (ICER) was calculated using costs and quality-adjusted life years (QALYs). Results: NGEMR was cost-effective and yielded a marginal health benefit (0.00006 QALYs gained) at a slightly higher cost (S $2.73; US $2.02), with an ICER of S $46,349 (US $34,298) per QALY. At the willingness-to-pay thresholds of 0.5- and 1-time gross domestic product (GDP) per capita (S $48,899; US $36,185 and S $97,798; US $72,371 per QALY), the implementation of NGEMR had a 52.2% and 64.7% probability of being cost-effective, respectively. The reduction in waiting time to see a specialist resulted in 2.3% fewer hospitalizations. The most influential parameter on the ICER was the probability of receiving duplicate tests, followed by the costs of admission and the probability of seeing a specialist. Reducing the probability of receiving duplicate tests for NGEMR from 20.7% to 13.2% resulted in a cost-saving ICER. A threshold analysis on the proportion of patients with a waiting time of less than 20 days for NGEMR was further explored, as it was a sensitive parameter on the cost-effectiveness of NGEMR. Increasing the proportion of patients with a waiting time of less than 20 days from 45.5% to 56% would result in cost savings for NGEMR. Conclusions: The adoption of NGEMR is cost-effective in Singapore. Beyond cost-effectiveness, the reduction of waiting time between primary and specialist care can lower the possibility of patients’ health deterioration, thus reducing hospital admissions. We recommend continuous monitoring of waiting times and the likelihood of having duplicate tests as countries transition from basic to advanced-level EMR systems. Future analyses could benefit from more granular data on timing and clinical indications and incorporate real-world local data as they become available through ongoing NGEMR rollout evaluations.

15 June 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
JSJarawee Sukmanee
Jarawee Sukmanee
PRPenkae Rothmanee
Penkae Rothmanee
WSWilaiwan Sriwimol
Wilaiwan Sriwimol
ASAnnetine Staff
Annetine Staff
TLTippawan Liabsuetrakul
Tippawan Liabsuetrakul
Objective: To assess the levels of blood pressure, cardiovascular biomarkers and their correlations measured within 7 years postpartum in women with previous pre-eclamptic pregnancies compared with women with previous normotensive pregnancies. Design: Cross-sectional study. Setting: Two tertiary hospitals in the southern region of Thailand. Participants: Women with pre-eclamptic and normotensive pregnancies in the past 7 years were enrolled from 1 October 2019 to 30 April 2021. Eligible women were interviewed, examined for body mass index (BMI) and blood pressure, and donated morning spot urine and blood samples. Primary outcome measures: Serum high-sensitivity C reactive protein, creatinine, fasting blood glucose (FBS), glycated haemoglobin (HbA1c), low-density lipoprotein (LDL) cholesterol, urine microalbumin to creatinine ratio (UACR) and sodium were measured. Group differences in biomarkers were tested using unpaired t-test, Wilcoxon rank-sum test or χ 2 test. The levels of blood pressure and biomarkers between the two study groups at 4 years were also compared. The correlations between blood pressure and biomarkers were analysed using Pearson’s correlation and partial correlation methods. Results: From 206 women included in the analysis, 88 had pre-eclamptic pregnancies and 118 had normotensive pregnancies. Compared with women with previous normotensive pregnancies, women with previous pre-eclamptic pregnancies had significantly increased rates of hypertension (31.8% vs 7.6%, p<0.001) and obesity (55.7% vs 40.7%, p=0.038), as well as higher serum levels of FBS (p<0.001), HbA1c (p<0.001), LDL cholesterol (p=0.03), creatinine (p<0.001) and UACR (p<0.001). Correlation coefficients of BMI, serum creatinine and UACR with blood pressure ranged from 0.27 to 0.31. Conclusion: The risk of hypertension after a pre-eclamptic pregnancy increased. Blood pressure measurement combined with BMI, serum creatinine and UACR screening at least once during 7 years postpartum is suggested for early detection of cardiovascular risk.

26 December 2024 in JMIR Preprints
Verified
Preprint
Open access
CCCynthia Chen
Cynthia Chen
JSJarawee Sukmanee
Jarawee Sukmanee
KSKhai Wee Soon
Khai Wee Soon
JLJulian Lim
Julian Lim
JDJared Louis Andre D'Souza
Jared Louis Andre D'Souza
Yot TeerawattananonYot Teerawattananon
Yot Teerawattananon
BACKGROUND With the vast development of technology and the evolving needs of patients and health care providers, electronic medical records (EMRs) have become a cornerstone for health information. However, different institutions have used different EMR systems. Our study investigates the potential benefits of implementing an integrated and common platform, known as the Next Generation Electronic Medical Record (NGEMR) in Singapore. The NGEMR allows improved data sharing between health care facilities and can promote better coordination between primary care and specialist care doctors to access patients’ records from the same database. OBJECTIVE This study aims to conduct an economic evaluation of the NGEMR to inform future health care system upgrades. METHODS A cost-utility analysis comparing NGEMR with the legacy EMR was conducted using a decision tree model with a 1-year time horizon from a health care system perspective. Input parameters of patients visiting primary care at the National University Polyclinics and specialist outpatient clinics from a General Hospital were extracted from the EMR systems. The incremental cost-effectiveness ratio (ICER) was calculated using costs and quality-adjusted life years (QALYs). RESULTS NGEMR was cost-effective and yielded a marginal health benefit (0.00006 QALYs gained) at a slightly higher cost (S $2.73; US $2.02), with an ICER of S $46,349 (US $34,298) per QALY. At the willingness-to-pay thresholds of 0.5- and 1-time gross domestic product (GDP) per capita (S $48,899; US $36,185 and S $97,798; US $72,371 per QALY), the implementation of NGEMR had a 52.2% and 64.7% probability of being cost-effective, respectively. The reduction in waiting time to see a specialist resulted in 2.3% fewer hospitalizations. The most influential parameter on the ICER was the probability of receiving duplicate tests, followed by the costs of admission and the probability of seeing a specialist. Reducing the probability of receiving duplicate tests for NGEMR from 20.7% to 13.2% resulted in a cost-saving ICER. A threshold analysis on the proportion of patients with a waiting time of less than 20 days for NGEMR was further explored, as it was a sensitive parameter on the cost-effectiveness of NGEMR. Increasing the proportion of patients with a waiting time of less than 20 days from 45.5% to 56% would result in cost savings for NGEMR. CONCLUSIONS The adoption of NGEMR is cost-effective in Singapore. Beyond cost-effectiveness, the reduction of waiting time between primary and specialist care can lower the possibility of patients’ health deterioration, thus reducing hospital admissions. We recommend continuous monitoring of waiting times and the likelihood of having duplicate tests as countries transition from basic to advanced-level EMR systems. Future analyses could benefit from more granular data on timing and clinical indications and incorporate real-world local data as they become available through ongoing NGEMR rollout evaluations.

22 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JSJarawee Sukmanee
Jarawee Sukmanee
NFNeil M. Ferguson
Neil M. Ferguson
PCPhornnaphat Chertchinnapa
Phornnaphat Chertchinnapa
CMClare McCormack
Clare McCormack
AVAnna Vicco
Anna Vicco
HTHugo C. Turner
Hugo C. Turner
Background: Dengue is highly endemic in many tropical and subtropical regions, including Thailand. As no specific treatment is available, vaccination is an important preventive strategy. The Qdenga (TAK-003) live-attenuated quadrivalent dengue vaccine is recommended by the World Health Organization for routine immunisation programmes in high-transmission settings with substantial disease burden. However, an independent country-specific economic evaluation is needed before inclusion in Thailand's National Immunization Program. This study evaluated the cost-effectiveness and budget impact of Qdenga vaccination strategies in Thailand.Methods: Cost-utility and budget impact analyses were conducted using a previously developed dengue transmission model. Qdenga vaccination scenarios, varying by vaccination age, vaccine mode of action (protection against disease only or against both disease and infection), and duration of waning (5 or 10 years), were compared with a no vaccination comparator. Costs and health outcomes, measured in quality-adjusted life years (QALYs), were projected over a 30-year time horizon.Findings: A national vaccination programme cumulatively targeting 15 million children aged 6 years could prevent 1·7 million symptomatic dengue cases and 382,000 hospitalisations. In the base-case analysis, routine vaccination targeting 6-year-olds would generate incremental costs of US$1,186 million and gain of 41,169 QALYs, resulting in an ICER of US$30,458/QALY. This exceeds Thailand's cost-effectiveness threshold (US$4,739/QALY) and yields an incremental net monetary benefit of –US$996 million. The annual government budget impact over the first five years was estimated to vary between US$66·4–70·9 million.Interpretation: Qdenga vaccination could substantially reduce symptomatic dengue cases and hospitalisations in Thailand. However, at its current price, the programme is unlikely to be cost-effective and would have a considerable budget impact. Price negotiation is therefore recommended before inclusion in the national immunisation programme.

1 September 2026 in JMIR Preprints
Verified
Preprint
Open access
ARAtiporn Rueangthaweep
Atiporn Rueangthaweep
KAKatika Akksilp
Katika Akksilp
PKPritaporn Kingkaew
Pritaporn Kingkaew
JSJarawee Sukmanee
Jarawee Sukmanee
TDThamonwan Dulsamphan
Thamonwan Dulsamphan
Yot TeerawattananonYot Teerawattananon
Yot Teerawattananon
BACKGROUND Health promotion funders increasingly need evidence of the health and economic impacts of their investments. However, the complex programs vary widely, making HTA-oriented impact evaluation difficult and resource-intensive. A practical screening approach is therefore needed to identify programs with sufficient evidence for further impact evaluation. OBJECTIVE This study aimed to develop the Health Promotion Categorisation Tool (HPCT), a screening tool to systematically classify health promotion programs by their readiness for HTA-orientated impact evaluation. METHODS The HPCT was developed through an iterative, stakeholder-engaged process comprised of three stages: (1) literature and document reviews and stakeholder-informed co-development, (2) multidisciplinary pilot testing and refinement, and (3) pre-liminary inter-rater reliability testing. The tool was refined using qualitative feedback, usability findings, completion time, and agreement between assessors. In Stage 3, two independent evaluators applied the finalized HPCT to 14 ThaiHealth-supported programs selected across different health promotion topics. Overall readiness agreement was assessed using percent agreement and Cohen’s kappa. RESULTS A total of 32 unique participants including health promotion program implementers, evaluators, policy makers, and HTA experts, contributed across the development stages. Stakeholder consultation informed the use of quality-adjusted life years and monetary benefits as impact metrics. The finalized HPCT consisted of three components: Program Information and Program Evaluation Matrix, Outcome Assessment, and a simplified Risk of Bias Assessment. A program was classified as ready when at least one relevant behavioral, clinical, or impact-related outcome was measured both before and after program implementation. Crude agreement during Stage 2 ranged from 75.0% to 91.7%. The mean completion time during pilot testing was 80.3 minutes (SD 31.1). In Stage 3, two evaluators agreed on 13 of 14 programs (92.9%), with a Cohen’s kappa of 0.837. The only disagreement involved a complex report in which relevant outcomes were not clearly reported. CONCLUSIONS HPCT offers a transparent and practical approach for assessing the readiness of health promotion programs for HTA-oriented impact evaluation. By providing consistent readiness criteria across diverse programs, HPCT can support more strategic allocation of evaluation resources and strengthen the generation of evidence for health and economic impact.